Workboat Indexes
Catalyst Pharm Inc (NQ: CPRX )
20.38
-0.17
(-0.83%)
Streaming Delayed Price
Updated: 10:46 AM EDT, Aug 27, 2024
Add to My Watchlist
Headline News about Catalyst Pharm Inc
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings For Catalyst Pharmaceuticals
August 12, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/08/14/Lab-People-Healthcare-thisisengineering-.jpeg?width=1200&height=800&fit=crop)
Top 3 Health Care Stocks That May Crash In August
August 14, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/07/30/Healthcare-Consulting.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Decoding 7 Analyst Evaluations For Catalyst Pharmaceuticals
March 27, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Catalyst Pharmaceuticals
February 27, 2024
Via Benzinga
![](https://g.foolcdn.com/editorial/images/777269/growth-stock.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://www.investors.com/wp-content/uploads/2024/05/TECH1_daly_051024.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://www.investors.com/wp-content/uploads/2022/09/Stock-CatalystPharmaceuticals-01-adobe.jpg)
![](https://investorplace.com/wp-content/uploads/2020/09/biotech-stocks.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/small-cap-1600-1024x576.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://g.foolcdn.com/editorial/images/767685/investor-inspects-papers-on-a-couch.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/29/image33.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.